Anne-Lise de Lastic

Prof. Dr. Anne-Lise de Lastic

Medical School, University of Patras, Patras, Achaea, Greece
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Autoimmunity Reviews
Verified
Journal Article
Closed access
KPKonstantia Psianou
Konstantia Psianou
IPIoannis Panagoulias
Ioannis Panagoulias
APAnastasios D. Papanastasiou
Anastasios D. Papanastasiou
Anne-Lise de LasticAnne-Lise de Lastic
Anne-Lise de Lastic
MRMaria Rodi
Maria Rodi
Athanasia MouzakiAthanasia Mouzaki
Athanasia Mouzaki

20 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KPKonstantina Pefani-Antimisiari
Konstantina Pefani-Antimisiari
DADimitrios K. Athanasopoulos
Dimitrios K. Athanasopoulos
Antonia MaraziotiAntonia Marazioti
Antonia Marazioti
KSKyriakos Sklias
Kyriakos Sklias
MRMaria Rodi
Maria Rodi
SASophia G. Antimisiaris
Sophia G. Antimisiaris
The aim of the present study was to investigate combined effects of cold atmospheric plasma (CAP) and the chemotherapeutic drug doxorubicin (DOX) on murine and human melanoma cells, and normal cells. In addition to free drug, the combination of CAP with a liposomal drug (DOX-LIP) was also studied for the first time. Thiazolyl blue tetrazolium bromide (MTT) and Trypan Blue exclusion assays were used to evaluate cell viability; the mechanism of cell death was evaluated by flow cytometry. Combined treatment effects on the clonogenic capability of melanoma cells, was also tested with soft agar colony formation assay. Furthermore the effect of CAP on the cellular uptake of DOX or DOX-LIP was examined. Results showed a strong synergistic effect of CAP and DOX or DOX-LIP on selectively decreasing cell viability of melanoma cells. CAP accelerated the apoptotic effect of DOX (or DOX-LIP) and dramatically reduced the aggressiveness of melanoma cells, as the combination treatment significantly decreased their anchorage independent growth. Moreover, CAP did not result in increased cellular uptake of DOX under the present experimental conditions. In conclusion, CAP facilitates DOX cytotoxic effects on melanoma cells, and affects their metastatic potential by reducing their clonogenicity, as shown for the first time.

2 June 2020 in Shock
Verified
Journal Article
Closed access
Stelios F. AssimakopoulosStelios F. Assimakopoulos
Stelios F. Assimakopoulos
IPIliana Papadopoulou
Iliana Papadopoulou
DBDimitra Bantouna
Dimitra Bantouna
Anne-Lise de LasticAnne-Lise de Lastic
Anne-Lise de Lastic
MRMaria Rodi
Maria Rodi
IMIoannis Maroulis
Ioannis Maroulis
Introduction: Sepsis is a life-threatening syndrome which can progress to multiple organ dysfunction with high mortality. Intestinal barrier failure exerts a central role in the pathophysiological sequence of events that lead from sepsis to multiple organ dysfunction. The present study investigated the role of hydrocortisone (HC) administration and fecal microbiota transplantation (FMT) in several parameters of the gut barrier integrity, immune activation, and survival, in a model of polymicrobial sepsis in rats. Methods: Forty adults male Wistar rats were randomly divided into four groups: sham (group I), cecal ligation and puncture (CLP) (group II), CLP + HC (2.8 mg/kg, intraperitoneally single dose at 6 h) (group III), and CLP + FMT at 6 h (group IV). At 24 h post-CLP, ileal tissues were harvested for histological and immunohistochemical analyses while endotoxin, IL-6, and IL-10 levels in systemic circulation were determined. In a second experiment the same groups were observed for 7 days for mortality, with daily administration of hydrocortisone (group III) and FMT (group IV) in surviving rats. Results: HC administration and FMT significantly reduced mortality of septic rats by 50%. These interventions totally reversed intestinal mucosal atrophy by increasing villous density and mucosal thickness (μm, mean ± SD: Group I: 620 ± 35, Group II: 411 ± 52, Group III: 622 ± 19, Group IV: 617 ± 44). HC and FMT reduced the apoptotic body count in intestinal crypts whereas these increased the mitotic/apoptotic index. Activated caspase-3 expression in intestinal crypts was significantly reduced by HC or FMT (activated caspase-3 (+) enterocytes/10 crypts, mean ± SD: Group I: 1.6 ± 0.5, Group II: 5.8 ± 2.4, Group III: 3.6 ± 0.9, Group IV: 2.3 ± 0.6). Both treatments increased Paneth cell count and decreased intraepithelial CD3(+) T lymphocytes and inflammatory infiltration of lamina propria to control levels. In the sham group almost the total of intestinal epithelial cells expressed occludin (92 ± 8%) and claudin-1 (98 ± 4%) and CLP reduced this expression to 34 ± 12% for occludin and 35 ± 7% for claudin-1. Administration of HC significantly increased occludin (51 ± 17%) and claudin-1 (77 ± 9%) expression. FMT exerted also a significant restoring effect in tight junction by increasing occludin (56 ± 15%) and claudin-1 (84 ± 7%) expression. The beneficial effects of these treatments on gut barrier function led to significant reduction of systemic endotoxemia (EU/mL, mean ± SD: Group I: 0.93 ± 0.36, Group II: 2.14 ± 1.74, Group III: 1.48 ± 0.53, Group IV: 1.61 ± 0.58), while FMT additionally decreased IL-6 and IL-10 levels. Conclusion: Fecal microbiota transplantation and stress dose hydrocortisone administration in septic rats induce a multifactorial improvement of the gut mechanical and immunological barriers, preventing endotoxemia and leading to improved survival.

1 February 2020 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
Stelios F. AssimakopoulosStelios F. Assimakopoulos
Stelios F. Assimakopoulos
KAKarolina Akinosoglou
Karolina Akinosoglou
Anne-Lise de LasticAnne-Lise de Lastic
Anne-Lise de Lastic
ASAikaterini Skintzi
Aikaterini Skintzi
AMAthanasia Mouzaki
Athanasia Mouzaki
CGCharalambos A. Gogos
Charalambos A. Gogos

31 December 2009 in Cytokine
Verified
Journal Article
Closed access
Athanasia MouzakiAthanasia Mouzaki
Athanasia Mouzaki
IPIoannis Panagoulias
Ioannis Panagoulias
ZDZoe Dervilli
Zoe Dervilli
VZVassiliki Zolota
Vassiliki Zolota
PSPanagiota Spadidea
Panagiota Spadidea
TGTassos Georgakopoulos
Tassos Georgakopoulos

Verified
Journal Article
Open access
PDF file
MRMaria Rodi
Maria Rodi
NDNikolaos Dimisianos
Nikolaos Dimisianos
Anne-Lise de LasticAnne-Lise de Lastic
Anne-Lise de Lastic
PSPanagiota Sakellaraki
Panagiota Sakellaraki
GDGeorge Deraos
George Deraos
Athanasia MouzakiAthanasia Mouzaki
Athanasia Mouzaki
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) of autoimmune etiology that results from an imbalance between CNS-specific T effector cells and peripheral suppressive mechanisms mediated by regulatory cells (RC). In this research, we collected blood samples from 83 relapsing remitting MS (RRMS) patients and 45 healthy persons (HC), to assess the sizes of their RC populations, including CD4+CD25highFoxp3+ (nTregs), CD3+CD4+HLA−G+, CD3+CD8+CD28−, CD3+CD56+, and CD56bright cells, and how RC are affected by disease activity (acute phase or remission) and types of treatment (methylprednisolone, interferon, or natalizumab). In addition, we isolated peripheral blood mononuclear cells (PBMC) and cultured them with peptides mapping to myelin antigens, to determine RC responsiveness to autoantigens. The results showed decreased levels of nTregs in patients in the acute phase ± methylprednisolone and in remission + natalizumab, but HC levels in patients in remission or receiving interferon. Patients + interferon had the highest levels of CD3+CD4+HLA−G+ and CD3+CD8+CD28− RC, and patients in the acute phase + methylprednisolone the lowest. Patients in remission had the highest levels of CD3+CD56+, and patients in remission + natalizumab the highest levels of CD56bright cells. Only nTregs responded to autoantigens in culture, regardless of disease activity or treatment. The highest suppressive activity was exhibited by nTregs from patients in remission. In conclusion, in RRMS disease activity and type of treatment affect different RC populations. nTregs respond to myelin antigens, indicating that it is possible to restore immunological tolerance through nTreg induction.